Regulation of Rb and E2F by signal transduction cascades: Divergent effects of JNK1 and p38 kinases

EMBO Journal

Volumn 18, Issue 6, 1999, Pages 1559-1570

  Wang, Sheng ^a   Nath, Niharika ^a   Minden, Audrey ^b   Chellappan, Srikumar ^a  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cell cycle; E2F; Fas; Rb phosphorylation; Transcription

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DNA BINDING PROTEIN; FAS ANTIGEN; PHOSPHOTRANSFERASE; RETINOBLASTOMA PROTEIN; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR E2F; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0033559703     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.6.1559     Document Type: Article

References (63)

1. Adams, P.D. and Kaelin, W.J. (1996) The cellular effects of E2F overexpression. Curr. Top. Microbiol. Immunol., 208, 79-93.
2. Altiok, S., Xu, M. and Spiegelman, B.M. (1997) PPAR γ induces cell cycle withdrawl: inhibition of E2F/DP DNA-binding activity by down-regulation of PP2A. Genes Dev., 11, 1987-1998.
3. Beijersbergen, R.L. and Bernards, R. (1996) Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim. Biophys. Acta, 1287, 103-120.
4. Chellappan, S.P. (1994) The E2F transcription factor: Role in cell cycle regulation and differentiation. Mol. Cell. Differ., 2, 201-220.
5. Chellappan, S.P., Hiebert, S., Mudryj, M., Horowitz, J.M. and Nevins, J.R. (1991) The E2F transcription factor is a cellular target for the RB protein. Cell, 65, 1053-1061.
6. Chellappan, S., Kraus, V.B., Kroger, B., Munger, K., Howley, P.M., Phelps, W.C. and Nevins, J.R. (1992) Adenovirus E1A, simian virus 40 tumor antigen and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma. Proc. Natl Acad. Sci. USA, 89, 4549-4553.
7. Chen, W.D., Otterson, G.A., Lipkowitz, S., Khleif, S.N., Coxon, A.B. and Kaye, F.J. (1997) Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene, 14, 1243-1248.
8. Cobrinik, D. (1996) Regulatory interactions among E2Fs and cell cycle control proteins. Curr. Top. Microbiol. Immunol., 208, 32-63.
9. Corbeil, H.B., Whyte, P. and Branton, P.E. (1995) Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Oncogene, 11, 909-920.
10. De Luca, A., De Maria, R., Baldi, A., Trotta, R., Facchiano, F., Giordano, A., Testi, R. and Condorelli, G. (1997) Fas-induced changes in cdc2 and cdk2 kinase activity are not sufficient for triggering apoptosis in HUT-78 cells. J. Cell Biochem., 64, 579-585.
11. 1 cyclin-dependent kinase activity. Genes Dev., 9, 2873-2887.
12. DeGregori, J., Leone, G., Miron, A., Jakoi, L. and Nevins, J.R. (1997) Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Nail Acad. Sci. USA, 94, 7245-7250.
13. Dou, Q.P., An, B., Antoku, K. and Johnson, D.E. (1997) Fas stimulation induces RB dephosphorylation and proteolysis that is blocked by inhibitors of the ICE protease family. J. Cell Biochem., 64, 586-594.
14. Dyson, N. (1994) pRB, p107 and the regulation of the E2F transcription factor. J. Cell Sci. Suppl., 18, 81-87.
15. Fiers, W. et al. (1995) TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis. J. Inflamm., 47, 67-75.
16. Helin, K., Lees J.A., Vidal, M., Dyson, N., Harlow, E. and Fattaey, A. (1992) A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell, 70, 337-350.
17. Hibi, M., Lin, A., Smeal, T., Minden, A. and Karin, M. (1993) Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev., 7, 2135-2148.
18. Hiebert, S.W., Chellappan, S.P., Horowitz, J.M. and Nevins, J.R. (1992) The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev., 6, 177-185.
19. Hiebert, S.W., Packham, G., Strom, D.K., Haffner, R., Oren, M., Zambetti, G. and Cleveland, J.L. (1995) E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol. Cell. Biol., 15, 6864-6874.
20. Hseih, J.-K., Fredersdorf, S., Kouzarides, T., Martin, K. and Lu, X. (1997) E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev., 11, 1840-1852.
21. Ikeda, M.A., Jakoi, L. and Nevins, J.R. (1996) A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl Acad. Sci. USA, 93, 3215-3220.
22. Janicke, R.U., Walker, P.A., Lin, X.Y. and Porter, A.G. (1996) Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J., 15, 6969-6978.
23. Johnson, D.G., Schwarz, J.K., Cress, W.D. and Nevins, J.R. (1993) Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature, 365, 349-352.
24. Juo, P., Kuo, C.J., Reynolds, S.E., Konz, R.F., Raingeaud, J., Davis, R.J., Bieman, H.-P. and Blenis, J. (1997) Fas activation of the p38 mitogen-activated protein kinase signaling pathway requires ICE/CED-3 family proteases. Mol. Cell. Biol., 17, 24-35.
25. Kaelin, W.G. et al. (1992) Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell, 70, 351-364.
26. Kallunki, T., Deng, T., Hibi, M. and Karin, M. (1996) c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell, 87, 929-940.
27. Karin, M. (1994) Signal transduction from the cell surface to the nucleus through the phosphorylalion of transcription factors. Curr. Opin. Cell Biol., 6, 415-424.
28. Kato, J., Matsushime, H., Hiebert, S.W., Ewen, M.E. and Sherr, C.J. (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev., 7, 331-342.
29. Kowalik, T.F., DeGregori, J., Leone, G., Jakoi, L. and Nevins J.R. (1998) E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell Growth Differ., 9, 113-118.
30. Krek, W., Ewen, M.E., Shirodkar, S., Arany, Z., Kaelin, W.J., Jr and Livingston, D.M. (1994) Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell, 78, 161-172.
31. Krek, W., Xu, G. and Livingston, D.M. (1995) Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell, 83, 1149-1158.
32. Kumar, S., McDonnell, P.C., Gum, R.J., Hand, A.T., Lee, J.C. and Young, P.R. (1997) Novel homologues of CSBP/p38 MAP kinase: activation, sunstrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem. Biophys. Res. Commun., 235, 533-538.
33. Kyriakis, J.M. and Avruch, J. (1996) Protein kinase cascades activated by stress and inflammatory cytokines. BioEssays, 18, 567-577.
34. La Thangue, N.B. (1994) DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci., 19, 108-114.
35. La Thangue, N.B. (1996) E2F and the molecular mechanisms of early cell-cycle control. Biochem. Soc. Trans., 24, 54-59.
36. Lee, J.C., Laydon, J.T., McDonnell, P.C., Gallagher, T.F., Kumar, S., Green, D., McNulty, D. and et al. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature, 372, 739-746.
37. Lees, J.A., Buchkovich, K.J., Marshak, D.R., Anderson, C.W. and Harlow, E. (1991) The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J., 10, 4279-4290.
38. Lenczowski, J.K., Dominguez, L., Eder, A.M., King, L.B., Zacharchuk, C.M. and Ashwel, J.D. (1997) Lack of a role for Jun Kinase and AP-1 in Fas-induced apoptosis. Mol. Cell. Biol., 17, 170-181.
39. Lundberg, A.S. and Weinberg, R.A. (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol., 18, 753-761.
40. Minden, A., Lin, A., McMahon, M., Lange, C.C., Derijard, B., Davis, R.J., Johnson, G.L. and Karin, M. (1994a) Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science, 266, 1719-1723.
41. Minden, A., Lin, A., Smeal, T., Derijard, B., Cobb, M., Davis, R. and Karin, M. (1994b) c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol. Cell. Biol., 14, 6683-6688.
42. Minden, A., Lin, A., Claret, F.-X., Abo, A. and Karin, M. (1995) Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell, 81, 1147-1157.
43. Nevins, J.R. (1992) Transcriptional regulation. A closer look at E2F. Nature, 83, 609-617.
44. Nevins, J.R. (1993) Disruption of cell-cycle control by viral oncoproteins. Biochem. Soc. Trans., 21, 935-938.
45. Nevins, J.R. (1994) Cell cycle targets of the DNA tumor viruses. Curr. Opin. Genet. Dev., 4, 130-134.
46. Nevins, J.R. (1998) Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ., 9, 585-593.
47. Oguri, H.N., Takahashi, S., Nakagawa, T. and Kikuchi, K. (1995) Selective depletion of cyclin-dependent kinases is associated with Fas-mediated apoptosis in human leukemia T-cell lines. Int. J. Immunopharmacol., 17, 913-921.
48. Phillips, A.C., Bates, S., Ryan, K.M., Helin, K. and Vousde, K.H. (1997) Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev., 11, 1853-1863.
49. Qin, X.Q., Livingston, D.M., Kaelin, W.J. and Adams, P.D. (1994) Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl Acad. Sci. USA, 91, 10918-10922.
50. Qin, X.Q., Livingston, D.M., Ewen, M., Sellers, W.R., Arany, Z. and Kaelin, W.G., Jr (1995) The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol., 15, 742-755.
51. 1→S transition of mammalian cells. J. Cell Biochem., 54, 379-386.
52. Rosette, C. and Karin, M. (1996) Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science, 274, 1194-1197.
53. Sellers, W.R., Novitch, B.G., Miyake, S., Heith, A., Otterson, G.A., Kaye, F.J., Lassar, A.B. and Kaelin, W.G., Jr (1998) Stable binding to E2F is not required for the retinoblastoma protein to activate transcription. promote differentiation and suppress tumor cell growth. Genes Dev., 12, 95-106.
54. Shan, B. and Lee, W.H. (1994) Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol., 14, 8166-8173.
55. Sherr, C.J. (1994) The ins and outs of RB: Coupling gene expression to the cell cycle clock. Trends Cell Biol., 4, 15-18.
56. Taya, Y. (1997) RB kinases and RB-binding proteins: new points of view. Trends Biochem. Sci., 22, 14-17.
57. Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
58. Weintraub, S.J., Chow, K.N., Luo, R.X., Zhang, S.H., He, S. and Dean, D.C. (1995) Mechanism of active transcriptional repression by the retinoblastoma protein. Nature, 375, 812-815.
59. Whitmarsh, A.J. and Davis, R.J. (1996) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med., 74, 589-607.
60. Xia, Z., Dickens, M., Raingeaud J., Davis, R.J. and Greenberg, M.E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 1326-1331.
61. Xu, M., Sheppard, K.A., Peng, C.Y., Yee, A.S. and Piwnica, W.H. (1994) Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol., 14, 8420-8431.
62. Young, P.R. et al. (1997) Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J. Biol. Chem., 272, 12116-12121.
63. Zhang, Y. and Chellappan, S.P. (1995) Cloning and characterization of DP2, a novel dimerization partner of E2F. Oncogene, 10, 2085-2093.